BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 25333655)

  • 21. Naphthoquinone-mediated inhibition of lysine acetyltransferase KAT3B/p300, basis for non-toxic inhibitor synthesis.
    Vasudevarao MD; Mizar P; Kumari S; Mandal S; Siddhanta S; Swamy MM; Kaypee S; Kodihalli RC; Banerjee A; Naryana C; Dasgupta D; Kundu TK
    J Biol Chem; 2014 Mar; 289(11):7702-17. PubMed ID: 24469461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oligomers of human histone chaperone NPM1 alter p300/KAT3B folding to induce autoacetylation.
    Kaypee S; Sahadevan SA; Sudarshan D; Halder Sinha S; Patil S; Senapati P; Kodaganur GS; Mohiyuddin A; Dasgupta D; Kundu TK
    Biochim Biophys Acta Gen Subj; 2018 Aug; 1862(8):1729-1741. PubMed ID: 29746960
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery of Highly Potent, Selective, and Orally Efficacious p300/CBP Histone Acetyltransferases Inhibitors.
    Yang Y; Zhang R; Li Z; Mei L; Wan S; Ding H; Chen Z; Xing J; Feng H; Han J; Jiang H; Zheng M; Luo C; Zhou B
    J Med Chem; 2020 Feb; 63(3):1337-1360. PubMed ID: 31910017
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Azide-alkyne cycloaddition affording enzymatically tunable bisubstrate based inhibitors of histone acetyltransferase PCAF.
    van Ameijde J; Zwiebel AP; Ruijtenbeek R; Liskamp RM
    Bioorg Med Chem Lett; 2014 Jan; 24(1):113-6. PubMed ID: 24345448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P300/CBP associated factor regulates nitroglycerin-dependent arterial relaxation by N(ε)-lysine acetylation of contractile proteins.
    Colussi C; Scopece A; Vitale S; Spallotta F; Mattiussi S; Rosati J; Illi B; Mai A; Castellano S; Sbardella G; Farsetti A; Capogrossi MC; Gaetano C
    Arterioscler Thromb Vasc Biol; 2012 Oct; 32(10):2435-43. PubMed ID: 22859492
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of protein acetyltransferase structure-function relation by surface-enhanced raman scattering (SERS): a tool to screen and characterize small molecule modulators.
    Arif M; Karthigeyan D; Siddhanta S; Kumar GV; Narayana C; Kundu TK
    Methods Mol Biol; 2013; 981():239-61. PubMed ID: 23381867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Discovery and biological evaluation of thiobarbituric derivatives as potent p300/CBP inhibitors.
    Lu W; Xiong H; Chen Y; Wang C; Zhang H; Xu P; Han J; Xiao S; Ding H; Chen Z; Lu T; Wang J; Zhang Y; Yue L; Liu YC; Zhang C; Yang Y; Jiang H; Chen K; Zhou B; Luo C
    Bioorg Med Chem; 2018 Nov; 26(20):5397-5407. PubMed ID: 30297119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.
    Chen J; Li Q
    Methods Mol Biol; 2013; 977():353-7. PubMed ID: 23436376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonhistone targets of KAT2A and KAT2B implicated in cancer biology
    Bondy-Chorney E; Denoncourt A; Sai Y; Downey M
    Biochem Cell Biol; 2019 Feb; 97(1):30-45. PubMed ID: 29671337
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Specific inhibition of p300-HAT alters global gene expression and represses HIV replication.
    Mantelingu K; Reddy BA; Swaminathan V; Kishore AH; Siddappa NB; Kumar GV; Nagashankar G; Natesh N; Roy S; Sadhale PP; Ranga U; Narayana C; Kundu TK
    Chem Biol; 2007 Jun; 14(6):645-57. PubMed ID: 17584612
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation.
    Nagy Z; Tora L
    Oncogene; 2007 Aug; 26(37):5341-57. PubMed ID: 17694077
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones.
    Deng L; de la Fuente C; Fu P; Wang L; Donnelly R; Wade JD; Lambert P; Li H; Lee CG; Kashanchi F
    Virology; 2000 Nov; 277(2):278-95. PubMed ID: 11080476
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PCAF histone acetyltransferase and cytotoxic effect of N-acylanthranilic acids.
    Park WJ; Ma E
    Arch Pharm Res; 2012 Aug; 35(8):1379-86. PubMed ID: 22941480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HIV-1 tat transcriptional activity is regulated by acetylation.
    Kiernan RE; Vanhulle C; Schiltz L; Adam E; Xiao H; Maudoux F; Calomme C; Burny A; Nakatani Y; Jeang KT; Benkirane M; Van Lint C
    EMBO J; 1999 Nov; 18(21):6106-18. PubMed ID: 10545121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Chemical Biology Approaches for Investigating the Functions of Lysine Acetyltransferases.
    He M; Han Z; Liu L; Zheng YG
    Angew Chem Int Ed Engl; 2018 Jan; 57(5):1162-1184. PubMed ID: 28786225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Complex functions of Gcn5 and Pcaf in development and disease.
    Koutelou E; Farria AT; Dent SYR
    Biochim Biophys Acta Gene Regul Mech; 2021 Feb; 1864(2):194609. PubMed ID: 32730897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defining Metabolic and Nonmetabolic Regulation of Histone Acetylation by NSAID Chemotypes.
    Shrimp JH; Garlick JM; Tezil T; Sorum AW; Worth AJ; Blair IA; Verdin E; Snyder NW; Meier JL
    Mol Pharm; 2018 Mar; 15(3):729-736. PubMed ID: 29240439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Controlling Intramolecular Interactions in the Design of Selective, High-Affinity Ligands for the CREBBP Bromodomain.
    Brand M; Clayton J; Moroglu M; Schiedel M; Picaud S; Bluck JP; Skwarska A; Bolland H; Chan AKN; Laurin CMC; Scorah AR; See L; Rooney TPC; Andrews KH; Fedorov O; Perell G; Kalra P; Vinh KB; Cortopassi WA; Heitel P; Christensen KE; Cooper RI; Paton RS; Pomerantz WCK; Biggin PC; Hammond EM; Filippakopoulos P; Conway SJ
    J Med Chem; 2021 Jul; 64(14):10102-10123. PubMed ID: 34255515
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells.
    Fioravanti R; Tomassi S; Di Bello E; Romanelli A; Plateroti AM; Benedetti R; Conte M; Novellino E; Altucci L; Valente S; Mai A
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32650558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Discordant Effects of Putative Lysine Acetyltransferase Inhibitors in Biochemical and Living Systems.
    Henry RA; Kuo YM; Siegel ZS; Yen TJ; Rhodes J; Taylor EA; Andrews AJ
    Cells; 2019 Sep; 8(9):. PubMed ID: 31480793
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.